Original Literature | Model OverView |
---|---|
Publication
Title
Principles of interleukin (IL)-6-type cytokine signalling and its regulation.
Affiliation
Institut fur Biochemie, RWTH Aachen, Universitatsklinikum, Pauwelsstrasse 30,D-52074 Aachen, Germany. heinrich@rwth-aachen.de
Abstract
The IL (interleukin)-6-type cytokines IL-6, IL-11, LIF (leukaemia inhibitoryfactor), OSM (oncostatin M), ciliary neurotrophic factor, cardiotrophin-1 andcardiotrophin-like cytokine are an important family of mediators involved in theregulation of the acute-phase response to injury and infection. Besides theirfunctions in inflammation and the immune response, these cytokines play also acrucial role in haematopoiesis, liver and neuronal regeneration, embryonaldevelopment and fertility. Dysregulation of IL-6-type cytokine signallingcontributes to the onset and maintenance of several diseases, such as rheumatoidarthritis, inflammatory bowel disease, osteoporosis, multiple sclerosis andvarious types of cancer (e.g. multiple myeloma and prostate cancer). IL-6-typecytokines exert their action via the signal transducers gp (glycoprotein) 130,LIF receptor and OSM receptor leading to the activation of the JAK/STAT (Januskinase/signal transducer and activator of transcription) and MAPK(mitogen-activated protein kinase) cascades. This review focuses on recentprogress in the understanding of the molecular mechanisms of IL-6-type cytokinesignal transduction. Emphasis is put on the termination and modulation of theJAK/STAT signalling pathway mediated by tyrosine phosphatases, the SOCS(suppressor of cytokine signalling) feedback inhibitors and PIAS (proteininhibitor of activated STAT) proteins. Also the cross-talk between the JAK/STATpathway with other signalling cascades is discussed.
PMID
12773095
|
Entity
Process
PI3K
--
MO000000030
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m135
10
infinite
0
TRANSPATH | MO000000030 |
--
Vav
--
MO000000044
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m117
10
infinite
0
InterPro | IPR001452 |
TRANSPATH | MO000000044 |
--
Jak1
--
MO000000145
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m129
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000145 |
--
Jak2
--
MO000000146
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m130
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000146 |
--
Tyk2
--
MO000000148
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m132
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000148 |
--
IRS-1
--
MO000000154
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m137
10
infinite
0
InterPro | IPR002404 |
TRANSPATH | MO000000154 |
--
TNF-alpha
--
MO000000289
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m230
10
infinite
0
InterPro | IPR003636 |
TRANSPATH | MO000000289 |
--
STAT1{active}
--
MO000013119
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1357
10
infinite
0
InterPro | IPR008967 |
TRANSPATH | MO000013119 |
--
STAT3
--
MO000013122
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1360
10
infinite
0
InterPro | IPR008967 |
TRANSPATH | MO000013122 |
--
IFNgamma
--
MO000016665
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1639
10
infinite
0
InterPro | IPR002069 |
TRANSPATH | MO000016665 |
--
STAT5
--
MO000016876
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1798
10
infinite
0
TRANSPATH | MO000016876 |
--
SOCS-1
--
MO000017004
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1906
10
infinite
0
InterPro | IPR001496 |
TRANSPATH | MO000017004 |
--
IL-2
--
MO000017061
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1954
10
infinite
0
TRANSPATH | MO000017061 |
--
PKCdelta
--
MO000017065
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1957
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000017065 |
--
SOCS-3
--
MO000017121
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2005
10
infinite
0
InterPro | IPR001496 |
TRANSPATH | MO000017121 |
--
Nmi
--
MO000017277
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2131
10
infinite
0
TRANSPATH | MO000017277 |
--
caveolin-1
--
MO000017526
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m2322
10
infinite
0
InterPro | IPR001612 |
TRANSPATH | MO000017526 |
--
PIAS1
--
MO000017700
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2460
10
infinite
0
InterPro | IPR004181 |
TRANSPATH | MO000017700 |
--
elongin C
--
MO000018946
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m3558
10
infinite
0
InterPro | IPR001232 |
TRANSPATH | MO000018946 |
--
LIFR:gp130
--
MO000018967
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3578
10
infinite
0
TRANSPATH | MO000018967 |
--
CNTF:CNTFRalpha:LIFR:gp130
--
MO000018968
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3579
10
infinite
0
TRANSPATH | MO000018968 |
--
p300
--
MO000019984
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m4512
10
infinite
0
InterPro | IPR000433 |
TRANSPATH | MO000019984 |
--
IL-11Ralpha
--
MO000058820
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m33847
10
infinite
0
InterPro | IPR003961 |
TRANSPATH | MO000058820 |
--
CBP
--
MO000099682
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m72733
10
infinite
0
TRANSPATH | MO000099682 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
STAT5:CBP
--
e100
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m102
0
infinite
0
--
STAT3:p300
--
e101
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m103
0
infinite
0
--
STAT1:p300
--
e102
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m104
0
infinite
0
--
STAT5:p300
--
e103
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m105
0
infinite
0
--
STAT1:CBP:Nmi
--
e104
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m106
0
infinite
0
--
STAT5:CBP:Nmi
--
e105
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m107
0
infinite
0
--
SMRT:STAT5
--
e106
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m108
0
infinite
0
--
STAT3
--
e107
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m109
10
infinite
0
InterPro | IPR008967 |
TRANSPATH | MO000013122 |
--
csml-variable:Double
m110
0
infinite
0
--
STAT3:FKHR
--
e109
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m111
0
infinite
0
--
CNTF:CNTFRalpha
--
e11
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m11
0
infinite
0
--
mRNA
--
e110
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m112
0
infinite
0
--
csml-variable:Double
m114
0
infinite
0
--
EZI
--
e112
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m115
0
infinite
0
--
STAT3:EZI
--
e113
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m116
0
infinite
0
--
Rac-1
--
e115
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m119
0
infinite
0
--
Rac-1{active}
--
e116
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m120
0
infinite
0
--
PKCdelta{active}
--
e118
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m122
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000017065 |
--
PKCdelta{active}
--
e119
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m123
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000017065 |
--
OSM:OSMR:gp130
--
e12
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m12
0
infinite
0
--
SOCS3:Ras
--
e122
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m131
0
infinite
0
--
SOCS-3{p}
--
e123
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m127
10
infinite
0
InterPro | IPR001496 |
TRANSPATH | MO000017121 |
--
IL-6:IL-6Ralpha:gp130{2}{p}}:Jak1:SHP2{p}:Gab1{p}
--
e124
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m133
0
infinite
0
--
IL-6:IL-6Ralpha:gp130{2}{p}}:Jak1:SHP2{p}:Gab1{p}:PI3K
--
e126
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m136
0
infinite
0
--
PI3K:IRS-1
--
e127
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m138
0
infinite
0
--
STAT1:PIAS1
--
e128
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
csml-variable:Double
m139
0
infinite
0
--
DNA
--
e129
cso30:c:Dna
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m140
0
infinite
0
--
OSM:LIFR:gp130
--
e13
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m13
0
infinite
0
--
STAT1:DNA
--
e130
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m141
0
infinite
0
--
IL-6:IL-6Ralpha:gp130{2}{p}}:Jak1:SOCS1
--
e131
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m142
0
infinite
0
--
EpoR:SOCS-3
--
e132
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m143
0
infinite
0
--
IL-6:IL-6Ralpha:gp130{2}{p}}:Jak1:SOCS3
--
e133
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m144
0
infinite
0
--
LEPR:SOCS-3
--
e134
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
csml-variable:Double
m145
0
infinite
0
--
GCSFR:SOCS3
--
e135
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m146
0
infinite
0
--
SOCS-1:elongin C
--
e136
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m147
0
infinite
0
--
degradants
--
e137
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
csml-variable:Double
m148
0
infinite
0
--
Tel:Jak2
--
e138
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m149
0
infinite
0
--
IL-6:IL-6Ralpha:gp130:gp130
--
e15
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m15
0
infinite
0
--
IL-11:IL-11Ralpha:gp130:gp130
--
e16
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m16
0
infinite
0
--
LIF:LIFR:gp130
--
e17
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m17
0
infinite
0
--
CT-1:LIFR:gp130
--
e18
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m18
0
infinite
0
--
CLC:CNTFR
--
e19
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
CLC:CNTFR:LIFR:gp130
--
e20
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m20
0
infinite
0
--
ErbB2:gp130
--
e21
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m21
0
infinite
0
--
IL-6:IL-6Ralpha:gp130{2}:Jak1
--
e22
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m22
0
infinite
0
--
IL-6:IL-6Ralpha:gp130{2}:Jak2
--
e23
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m23
0
infinite
0
--
IL-6:IL-6Ralpha:gp130{2}{p}:TYK2
--
e24
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m24
0
infinite
0
--
OSM:OSMR:gp130:Jak1
--
e25
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m25
0
infinite
0
--
OSM:OSMR:gp130:Jak2
--
e26
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m26
0
infinite
0
--
OSM:OSMR:gp130{p}:TYK2
--
e27
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m27
0
infinite
0
--
LIF:LIFR:gp130:Jak1
--
e28
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m28
0
infinite
0
--
LIF:LIFR:gp130:Jak2
--
e29
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
LIF:LIFR:gp130{p}:TYK2
--
e30
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m30
0
infinite
0
--
IL-11:IL-11Ralpha:gp130:gp130:Hck
--
e31
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m31
0
infinite
0
--
IL-6:IL-6Ralpha:gp130:gp130:Cdk9
--
e34
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m35
0
infinite
0
--
IL-6:IL-6Ralpha:gp130:gp130:PKCdelta
--
e35
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m36
0
infinite
0
--
IFNalpha receptor 1
--
e36
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m37
0
infinite
0
--
IFNalpha receptor 1
--
e37
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m38
0
infinite
0
--
STAT3:caveolin-1
--
e38
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m39
0
infinite
0
--
STAT3:Hsp90
--
e39
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m40
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
STAT3{active}
--
e40
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m41
10
infinite
0
InterPro | IPR008967 |
TRANSPATH | MO000013122 |
--
STAT1
--
e41
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m42
10
infinite
0
InterPro | IPR008967 |
TRANSPATH | MO000013119 |
--
STAT5{active}
--
e42
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m43
10
infinite
0
TRANSPATH | MO000016876 |
--
IL-6:IL-6Ralpha:gp130{2}:TYK2
--
e43
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m44
0
infinite
0
--
LIF:LIFR:gp130:TYK2
--
e44
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m45
0
infinite
0
--
OSM:OSMR:gp130:TYK2
--
e45
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m46
0
infinite
0
--
IL-6:IL-6Ralpha:gp130{2}{p}:TYK2:STAT1
--
e46
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m47
0
infinite
0
--
IL-6:IL-6Ralpha:gp130{2}{p}:TYK2:STAT3
--
e47
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m48
0
infinite
0
--
LIF:LIFR:gp130{p}:TYK2:STAT3
--
e48
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m49
0
infinite
0
--
IL-6:IL-6Ralpha:gp130{2}{p}:TYK2:STAT1{p}
--
e49
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m63
0
infinite
0
--
IL-6:IL-6Ralpha
--
e5
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
IL-11:IL-11Ralpha
--
e6
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
IL-6:IL-6Ralpha:gp130{2}{p}:TYK2:STAT3{p}
--
e63
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m64
0
infinite
0
--
LIF:LIFR:gp130{p}:TYK2:STAT3{p}
--
e64
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m65
0
infinite
0
--
PRMT-1
--
e65
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m66
0
infinite
0
--
PRMT-1:IFNalpha receptor 1
--
e67
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m68
0
infinite
0
--
IFNbeta receptor 1
--
e68
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m69
0
infinite
0
--
PRMT-1:IFNbeta receptor 1
--
e69
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m70
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
IFN
--
e70
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m71
0
infinite
0
--
NPI-1
--
e71
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m72
0
infinite
0
--
Importin-alpha5
--
e72
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m73
0
infinite
0
--
Importin-alpha5{active}
--
e73
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m74
0
infinite
0
--
NPI-1{active}
--
e74
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m75
0
infinite
0
--
Ran
--
e75
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m76
0
infinite
0
--
STAT1{active}
--
e76
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m77
10
infinite
0
InterPro | IPR008967 |
TRANSPATH | MO000013119 |
--
CRM-1{active}
--
e77
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m78
0
infinite
0
--
CRM-1
--
e78
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m79
0
infinite
0
--
STAT1:Importin-alpha5
--
e79
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m80
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
csml-variable:Double
m81
0
infinite
0
--
OSM:OSMR:gp130:Jak1:shc{p}
--
e81
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m83
0
infinite
0
--
OSM:OSMR:gp130:Jak1:shc
--
e82
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m84
0
infinite
0
--
IL-6:IL-6Ralpha:gp130{2}{p}}:Jak1
--
e83
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m85
0
infinite
0
--
SHP2
--
e84
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m86
0
infinite
0
--
IL-6:IL-6Ralpha:gp130{2}{p}}:Jak1:SHP2
--
e85
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m87
0
infinite
0
--
IL-6:IL-6Ralpha:gp130{2}{p}}:Jak1:SHP2{p}
--
e86
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m88
0
infinite
0
--
Grb2:SOS
--
e87
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m89
0
infinite
0
--
IL-6:IL-6Ralpha:gp130{2}{p}}:Jak1:SHP2{p}:Grb2:SOS
--
e88
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m90
0
infinite
0
--
Gab1
--
e89
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m91
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
IL-6:IL-6Ralpha:gp130{2}{p}}:Jak1:SHP2{p}:Gab1
--
e90
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m92
0
infinite
0
--
Grb2
--
e91
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m93
0
infinite
0
--
OSM:OSMR:gp130:Jak1:shc{p}:grb2
--
e92
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m94
0
infinite
0
--
OSM:OSMR:gp130:Jak1:shc{p}:grb2:SOS
--
e93
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m95
0
infinite
0
--
ras{active}
--
e94
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m96
0
infinite
0
--
ras
--
e95
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m97
0
infinite
0
--
csml-variable:Double
m98
0
infinite
0
--
raf{active}
--
e97
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m99
0
infinite
0
--
STAT3:CBP
--
e98
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m100
0
infinite
0
--
STAT1:CBP
--
e99
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m101
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m871*m3096*0.1
nodelay
--
0
PMID: 12773095 IL-6, IL-11 and CNTF first bind specifically to their respective ¦Á-receptor subunits.
p8
p10
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c29 : 1
stoichiometry:c30 : 1
m472*m3578*0.1
nodelay
--
0
PMID: 12773095 The remaining IL-6 type cytokines signal via heterodimers of either gp130 and the LIFR (LIF, CNTF, CT-1 and CLC) or gp130 and the OSMR (OSM).
p100
p100
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c290 : 1
stoichiometry:c291 : 1
m117*0.1
nodelay
--
0
PMID: 12773095 A sequential activation of Vav, Rac-1, MKK-4 (MAP kinase kinase 4) and PKC¦Ä is necessary for the IL-6- mediated STAT3 Ser727 phosphorylation and transactivation in HepG2 cells.
p100
p101
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c293 : 1
stoichiometry:c292 : 1
stoichiometry:c294 : 1
m119*m118*0.1
nodelay
--
0
PMID: 12773095 A sequential activation of Vav, Rac-1, MKK-4 (MAP kinase kinase 4) and PKC¦Ä is necessary for the IL-6- mediated STAT3 Ser727 phosphorylation and transactivation in HepG2 cells.
p100
p102
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c295 : 1
stoichiometry:c296 : 1
stoichiometry:c297 : 1
m120*m1832*0.1
nodelay
--
0
PMID: 12773095 A sequential activation of Vav, Rac-1, MKK-4 (MAP kinase kinase 4) and PKC¦Ä is necessary for the IL-6- mediated STAT3 Ser727 phosphorylation and transactivation in HepG2 cells.
p100
p103
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c298 : 1
stoichiometry:c299 : 1
stoichiometry:c300 : 1
m121*m1957*0.1
nodelay
--
0
PMID: 12773095 A sequential activation of Vav, Rac-1, MKK-4 (MAP kinase kinase 4) and PKC¦Ä is necessary for the IL-6- mediated STAT3 Ser727 phosphorylation and transactivation in HepG2 cells.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c301 : 1
stoichiometry:c302 : 1
m122*0.1
nodelay
--
0
PMID: 12773095 A sequential activation of Vav, Rac-1, MKK-4 (MAP kinase kinase 4) and PKC¦Ä is necessary for the IL-6- mediated STAT3 Ser727 phosphorylation and transactivation in HepG2 cells. PMID: 12773095,11335711 Moreover, there is evidence that the PKC¦Ä-mediated STAT3 Ser727 phosphorylation occurs in the nucleus
p105
p105
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c303 : 1
stoichiometry:c304 : 1
stoichiometry:c306 : 1
stoichiometry:c305 : 1
m123*m109*m5*0.1
nodelay
--
0
PMID: 12773095 A sequential activation of Vav, Rac-1, MKK-4 (MAP kinase kinase 4) and PKC¦Ä is necessary for the IL-6- mediated STAT3 Ser727 phosphorylation and transactivation in HepG2 cells. PMID: 12773095,11335711 Moreover, there is evidence that the PKC¦Ä-mediated STAT3 Ser727 phosphorylation occurs in the nucleus
p82
p106
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c307 : 1
stoichiometry:c308 : 1
stoichiometry:c309 : 1
m99*m1812*0.1
nodelay
--
0
PMID: 12773095 Finally, recruitment of SOS to the receptor complex at the membrane allows Ras activation, which in turn leads to the activation of the Ras?Raf?MAPK cascade
p107
p107
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c312 : 1
stoichiometry:c310 : 1
stoichiometry:c311 : 1
m1954*0.1
nodelay
--
0
PMID: 12773095 In response to IL-2, Epo, EGF, and PDGF, SOCS3 (suppressor of cytokine signalling 3) becomes tyrosine phosphorylated, and subsequently binds and inactivates Ras/GTPase-activating protein.
p107
p108
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c313 : 1
stoichiometry:c314 : 1
stoichiometry:c315 : 1
m1958*m2005*0.1
nodelay
--
0
PMID: 12773095 In response to IL-2, Epo, EGF, and PDGF, SOCS3 (suppressor of cytokine signalling 3) becomes tyrosine phosphorylated, and subsequently binds and inactivates Ras/GTPase-activating protein.
p107
p109
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c316 : 1
stoichiometry:c317 : 1
stoichiometry:c318 : 1
m126*m2005*0.1
nodelay
--
0
PMID: 12773095 In response to IL-2, Epo, EGF, and PDGF, SOCS3 (suppressor of cytokine signalling 3) becomes tyrosine phosphorylated, and subsequently binds and inactivates Ras/GTPase-activating protein.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c32 : 1
stoichiometry:c33 : 1
m3578*m19*0.1
nodelay
--
0
PMID: 12773095 The remaining IL-6 type cytokines signal via heterodimers of either gp130 and the LIFR (LIF, CNTF, CT-1 and CLC) or gp130 and the OSMR (OSM).
p107
p110
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c319 : 1
stoichiometry:c320 : 1
stoichiometry:c321 : 1
m128*m2005*0.1
nodelay
--
0
PMID: 12773095 In response to IL-2, Epo, EGF, and PDGF, SOCS3 (suppressor of cytokine signalling 3) becomes tyrosine phosphorylated, and subsequently binds and inactivates Ras/GTPase-activating protein.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c322 : 1
stoichiometry:c323 : 1
stoichiometry:c324 : 1
m97*m127*0.1
nodelay
--
0
PMID: 12773095 In response to IL-2, Epo, EGF, and PDGF, SOCS3 (suppressor of cytokine signalling 3) becomes tyrosine phosphorylated, and subsequently binds and inactivates Ras/GTPase-activating protein.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c325 : 1
stoichiometry:c326 : 1
m92*0.1
nodelay
--
0
PMID: 12773095 In response to IL-6, Gab1 is tyrosine phosphorylated and interacts subsequently with SHP2 and PI3K.
p113
p113
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c327 : 1
stoichiometry:c328 : 1
stoichiometry:c329 : 1
m133*m554*0.1
nodelay
--
0
PMID: 12773095,9632795 Finally, IL-6-induced association of Gab1 with SHP2 leads to activation of ERK2
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c330 : 1
stoichiometry:c331 : 1
stoichiometry:c332 : 1
m135*m133*0.1
nodelay
--
0
PMID: 12773095,9632795 After IL-6 stimulation the adaptor protein Gab1 interacts with PI3K
p115
p115
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c333 : 1
stoichiometry:c334 : 1
stoichiometry:c336 : 1
stoichiometry:c335 : 1
m135*m137*m12*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c337 : 1
stoichiometry:c338 : 1
stoichiometry:c339 : 1
m42*m2460*0.1
nodelay
--
0
PMID: 12773095,11257227 As mentioned above, PIAS1 preferentially associates with unmethylated STAT1
p117
p117
cso30:i:ME_DNABinding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c340 : 1
stoichiometry:c341 : 1
stoichiometry:c343 : 1
stoichiometry:c342 : 1
m77*m140*0.1
nodelay
--
0
PMID: 12773095,9724754 Whereas PIAS1 specifically inhibits DNA binding of activated STAT1 and thus STAT1-mediated gene induction (after IFN stimulation)
p118
p118
cso30:i:ME_GeneExpression
cso30:i:CC_NuclearEnvelopeLumen
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c344 : 1
stoichiometry:c345 : 1
m141*0.1
nodelay
--
0
PMID: 12773095,9724754 Whereas PIAS1 specifically inhibits DNA binding of activated STAT1 and thus STAT1-mediated gene induction (after IFN stimulation)
p119
p119
cso30:i:ME_GeneExpression
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c346 : 1
stoichiometry:c348 : 1
stoichiometry:c352 : 1
stoichiometry:c347 : 1
m109*m5*0.1
nodelay
--
0
PMID: 12773095,9388184 PIAS3 was found to be specific for the inhibition of STAT3-mediated gene expression (after IL-6 stimulation)
p12
p12
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c34 : 1
stoichiometry:c35 : 1
stoichiometry:c36 : 1
m2935*m1854*0.1
nodelay
--
0
PMID: 12773095,9590694 Moreover, itwas reported that ErbB2 forms a complexwith gp130 in an IL-6-dependent manner in prostate carcinoma cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c349 : 1
stoichiometry:c350 : 1
stoichiometry:c351 : 1
m1906*m85*0.1
nodelay
--
0
PMID: 12773095 SOCS1 inhibits signal transduction by binding to the activation loop of the JAKs via its SH2 domain.
p121
p121
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c353 : 1
stoichiometry:c354 : 1
stoichiometry:c355 : 1
m82*m2005*0.1
nodelay
--
0
PMID: 12773095,10777583,10829066,10882725,11108838,11018044,12133942,12027890 SOCS3 associates with specific phosphotyrosine motifs within activated cytokine receptors, such as gp130, EpoR, leptin receptor and the granulocyte colony-stimulating factor receptor
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c356 : 1
stoichiometry:c357 : 1
stoichiometry:c358 : 1
m85*m2005*0.1
nodelay
--
0
PMID: 12773095,10777583,10829066,10882725,11108838,11018044,12133942,12027890 SOCS3 associates with specific phosphotyrosine motifs within activated cytokine receptors, such as gp130, EpoR, leptin receptor and the granulocyte colony-stimulating factor receptor
p121
p123
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c359 : 1
stoichiometry:c360 : 1
stoichiometry:c361 : 1
m41032*m2005*0.1
nodelay
--
0
PMID: 12773095,10777583,10829066,10882725,11108838,11018044,12133942,12027890 SOCS3 associates with specific phosphotyrosine motifs within activated cytokine receptors, such as gp130, EpoR, leptin receptor and the granulocyte colony-stimulating factor receptor
p121
p124
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c362 : 1
stoichiometry:c363 : 1
stoichiometry:c364 : 1
m2005*m63352*0.1
nodelay
--
0
PMID: 12773095,10777583,10829066,10882725,11108838,11018044,12133942,12027890 SOCS3 associates with specific phosphotyrosine motifs within activated cytokine receptors, such as gp130, EpoR, leptin receptor and the granulocyte colony-stimulating factor receptor
p125
p125
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c365 : 1
stoichiometry:c366 : 1
stoichiometry:c367 : 1
m1906*m3558*0.1
nodelay
--
0
PMID: 12773095 In this complex, the SOCS proteins interact with elongin C via the SOCS box.
p126
p126
cso30:i:ME_UnknownDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c368 : 1
stoichiometry:c369 : 1
stoichiometry:c370 : 1
m147*m130*0.1
nodelay
--
0
PMID: 12773095,11313480,11278610,11971965,12228220,10747851 Consistent with the postulated E3-ligase function are new findings that SOCS1 targets JAK2, Tel-JAK2 and IRS1/2, as well as Vav, to degradation
p126
p127
cso30:i:ME_UnknownDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c371 : 1
stoichiometry:c372 : 1
stoichiometry:c373 : 1
m147*m117*0.1
nodelay
--
0
PMID: 12773095,11313480,11278610,11971965,12228220,10747851 Consistent with the postulated E3-ligase function are new findings that SOCS1 targets JAK2, Tel-JAK2 and IRS1/2, as well as Vav, to degradation
p126
p128
cso30:i:ME_UnknownDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c374 : 1
stoichiometry:c375 : 1
stoichiometry:c376 : 1
m147*m137*0.1
nodelay
--
0
PMID: 12773095,11313480,11278610,11971965,12228220,10747851 Consistent with the postulated E3-ligase function are new findings that SOCS1 targets JAK2, Tel-JAK2 and IRS1/2, as well as Vav, to degradation
p126
p129
cso30:i:ME_UnknownDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c377 : 1
stoichiometry:c378 : 1
stoichiometry:c379 : 1
m147*m1789*0.1
nodelay
--
0
PMID: 12773095,11313480,11278610,11971965,12228220,10747851 Consistent with the postulated E3-ligase function are new findings that SOCS1 targets JAK2, Tel-JAK2 and IRS1/2, as well as Vav, to degradation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c38 : 1
stoichiometry:c64 : 1
stoichiometry:c39 : 1
m129*m15*0.1
nodelay
--
0
PMID: 12773095,8272872,11786531,10586060 The signal transducing chains gp130, LIFR and OSMR bind to JAK1, JAK2and TYK2
p126
p130
cso30:i:ME_UnknownDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c380 : 1
stoichiometry:c381 : 1
stoichiometry:c382 : 1
m147*m149*0.1
nodelay
--
0
PMID: 12773095,11313480,11278610,11971965,12228220,10747851 Consistent with the postulated E3-ligase function are new findings that SOCS1 targets JAK2, Tel-JAK2 and IRS1/2, as well as Vav, to degradation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c37 : 1
stoichiometry:c42 : 1
m130*m15*0.1
nodelay
--
0
PMID: 12773095,8272872,11786531,10586060 The signal transducing chains gp130, LIFR and OSMR bind to JAK1, JAK2and TYK2
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c43 : 1
stoichiometry:c41 : 1
stoichiometry:c45 : 1
m132*m15*0.1
nodelay
--
0
PMID: 12773095,8272872,11786531,10586060 The signal transducing chains gp130, LIFR and OSMR bind to JAK1, JAK2and TYK2
p35
p16
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c47 : 1
stoichiometry:c48 : 1
m27*m42*0.1
nodelay
--
0
PMID: 12773095,9716487 All IL-6-type cytokines potently activate STAT3, and to a minor extent STAT1 through their common receptor subunit gp130
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c49 : 1
stoichiometry:c50 : 1
stoichiometry:c51 : 1
m130*m12*0.1
nodelay
--
0
PMID: 12773095,8272872,11786531,10586060 The signal transducing chains gp130, LIFR and OSMR bind to JAK1, JAK2and TYK2
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c52 : 1
stoichiometry:c53 : 1
stoichiometry:c54 : 1
m132*m12*0.1
nodelay
--
0
PMID: 12773095,8272872,11786531,10586060 The signal transducing chains gp130, LIFR and OSMR bind to JAK1, JAK2and TYK2
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c55 : 1
stoichiometry:c56 : 1
stoichiometry:c57 : 1
m129*m17*0.1
nodelay
--
0
PMID: 12773095,8272872,11786531,10586060 The signal transducing chains gp130, LIFR and OSMR bind to JAK1, JAK2and TYK2
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m1859*m33847*0.1
nodelay
--
0
PMID: 12773095 IL-6, IL-11 and CNTF first bind specifically to their respective ¦Á-receptor subunits.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c59 : 1
stoichiometry:c60 : 1
m130*m17*0.1
nodelay
--
0
PMID: 12773095,8272872,11786531,10586060 The signal transducing chains gp130, LIFR and OSMR bind to JAK1, JAK2and TYK2
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c61 : 1
stoichiometry:c62 : 1
stoichiometry:c63 : 1
m132*m17*0.1
nodelay
--
0
PMID: 12773095,8272872,11786531,10586060 The signal transducing chains gp130, LIFR and OSMR bind to JAK1, JAK2and TYK2
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c44 : 1
stoichiometry:c65 : 1
stoichiometry:c66 : 1
m751*m15*0.1
nodelay
--
0
PMID: 12773095,11689697 The Src family kinase Hck has recently been shown to associate with an acidic region (amino acids 771?811) of gp130
p23
p23
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c67 : 1
stoichiometry:c68 : 1
stoichiometry:c69 : 1
m15*m32*0.1
nodelay
--
0
PMID: 12773095,11689697 Deletion of these amino acids reduces IL-6-induced Hck kinase activity, ERK (extracellular-regulated kinase) activation, dephosphorylation of Pyk2 and proliferation of transfected pro- B Ba/F3 cells
p24
p24
cso30:i:ME_Dephosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c70 : 1
stoichiometry:c71 : 1
stoichiometry:c72 : 1
m15*m1785*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c73 : 1
stoichiometry:c74 : 1
stoichiometry:c75 : 1
m15*m2515*0.1
nodelay
--
0
PMID: 12773095,12386808 Cdk9 (cyclin-dependent kinase 9) was also found to bind to gp130, and the association increased upon IL-6 stimulation of HEK 293 cells over-expressing gp130 and Cdk9
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c76 : 1
stoichiometry:c77 : 1
stoichiometry:c78 : 1
m15*m1957*0.1
nodelay
--
0
PMID: 12773095,12361954 PKCdelta (protein kinase Cdelta), a kinase implicated in serine phosphorylation of STAT3 (see below), has been found in a complex with gp130 upon IL-6 stimulation
p27
p27
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c79 : 1
stoichiometry:c80 : 1
stoichiometry:c81 : 1
stoichiometry:c82 : 1
m132*m129*m130*0.1
nodelay
--
0
PMID: 12773095 Co-expression of JAK1, JAK2 and TYK2 substantially enhances the surface expression of the human OSMR.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c84 : 1
stoichiometry:c83 : 1
m95214*0.1
nodelay
--
0
PMID: 12773095 Co-expression of JAK1, JAK2 and TYK2 substantially enhances the surface expression of the human OSMR.
p29
p29
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c85 : 1
stoichiometry:c86 : 1
m130*0.1
nodelay
--
0
PMID: 12773095 Similarly, JAK2 is crucial for EpoR surface expression.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
m434*m1857*0.1
nodelay
--
0
PMID: 12773095 IL-6, IL-11 and CNTF first bind specifically to their respective ¦Á-receptor subunits.
p30
p30
cso30:i:ME_Translation
cso30:i:CC_NuclearChromosome
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c88 : 1
stoichiometry:c87 : 1
m93473*0.1
nodelay
--
0
PMID: 12773095 Similarly, JAK2 is crucial for EpoR surface expression.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c91 : 1
stoichiometry:c92 : 1
m37*0.1
nodelay
--
0
--
p32
p32
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c89 : 1
stoichiometry:c90 : 1
m132*0.1
nodelay
--
0
PMID: 12773095,9342324 TYK2 is important for surface expression of the IFNalpha receptor 1 chain
p33
p33
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c93 : 1
stoichiometry:c94 : 1
stoichiometry:c95 : 1
m2322*m1360*0.1
nodelay
--
0
PMID: 12773095,12235142 In addition, STAT3 was reported to be associated with both caveolin-1 and heat-shock protein-90 in these rafts, as well as in the cytosol
p33
p34
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c96 : 1
stoichiometry:c97 : 1
stoichiometry:c98 : 1
m1360*m5516*0.1
nodelay
--
0
PMID: 12773095,12235142 In addition, STAT3 was reported to be associated with both caveolin-1 and heat-shock protein-90 in these rafts, as well as in the cytosol
p35
p35
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c99 : 1
stoichiometry:c100 : 1
stoichiometry:c236 : 1
stoichiometry:c237 : 1
stoichiometry:c101 : 1
m24*m1360*0.1
nodelay
--
0
PMID: 12773095,9716487 All IL-6-type cytokines potently activate STAT3, and to a minor extent STAT1 through their common receptor subunit gp130
p35
p36
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c102 : 1
stoichiometry:c103 : 1
stoichiometry:c104 : 1
m24*m42*0.1
nodelay
--
0
PMID: 12773095,9716487 All IL-6-type cytokines potently activate STAT3, and to a minor extent STAT1 through their common receptor subunit gp130
p35
p37
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c105 : 1
stoichiometry:c106 : 1
stoichiometry:c107 : 1
m16*m42*0.1
nodelay
--
0
PMID: 12773095,9716487 All IL-6-type cytokines potently activate STAT3, and to a minor extent STAT1 through their common receptor subunit gp130
p35
p38
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c108 : 1
stoichiometry:c109 : 1
stoichiometry:c110 : 1
m16*m1360*0.1
nodelay
--
0
PMID: 12773095,9716487 All IL-6-type cytokines potently activate STAT3, and to a minor extent STAT1 through their common receptor subunit gp130
p35
p39
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c111 : 1
stoichiometry:c112 : 1
stoichiometry:c113 : 1
m3579*m42*0.1
nodelay
--
0
PMID: 12773095,9716487 All IL-6-type cytokines potently activate STAT3, and to a minor extent STAT1 through their common receptor subunit gp130
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
stoichiometry:c12 : 1
m1797*m3577*0.1
nodelay
--
0
PMID: 12773095 Human OSM has the exceptional capability to recruit two different receptor complexes. It forms both LIFR?gp130 and OSMR?gp130 heterodimers.
p35
p40
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c114 : 1
stoichiometry:c116 : 1
stoichiometry:c115 : 1
m1360*m3579*0.1
nodelay
--
0
PMID: 12773095,9716487 All IL-6-type cytokines potently activate STAT3, and to a minor extent STAT1 through their common receptor subunit gp130
p35
p41
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c118 : 1
stoichiometry:c117 : 1
stoichiometry:c119 : 1
m1360*m27*0.1
nodelay
--
0
PMID: 12773095,9716487 All IL-6-type cytokines potently activate STAT3, and to a minor extent STAT1 through their common receptor subunit gp130
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c121 : 1
stoichiometry:c120 : 1
stoichiometry:c122 : 1
m12*m129*0.1
nodelay
--
0
PMID: 12773095,8272872,11786531,10586060 The signal transducing chains gp130, LIFR and OSMR bind to JAK1, JAK2and TYK2
p35
p43
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c123 : 1
stoichiometry:c124 : 1
stoichiometry:c125 : 1
m30*m42*0.1
nodelay
--
0
PMID: 12773095,9716487 All IL-6-type cytokines potently activate STAT3, and to a minor extent STAT1 through their common receptor subunit gp130
p35
p44
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c126 : 1
stoichiometry:c127 : 1
stoichiometry:c128 : 1
m30*m1360*0.1
nodelay
--
0
PMID: 12773095,9716487 All IL-6-type cytokines potently activate STAT3, and to a minor extent STAT1 through their common receptor subunit gp130
p45
p45
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c129 : 1
stoichiometry:c130 : 1
stoichiometry:c131 : 1
m27*m1798*0.1
nodelay
--
0
PMID: 12773095,7797460 In the cases of LIFR and OSMR, STAT3 and STAT1, as well as STAT5, activation has been observed, withOSMRbeing the most potent activator of STAT5
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c132 : 1
stoichiometry:c133 : 1
m44*0.1
nodelay
--
0
PMID: 12773095, 8156998,7871433,7871432,8662795 The recruitment of STATs to the activated receptors has been shown to be mediated by their SH2 domain and requires the phosphorylation of receptor tyrosine motifs
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c134 : 1
stoichiometry:c135 : 1
m45*0.1
nodelay
--
0
PMID: 12773095, 8156998,7871433,7871432,8662795 The recruitment of STATs to the activated receptors has been shown to be mediated by their SH2 domain and requires the phosphorylation of receptor tyrosine motifs
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c137 : 1
stoichiometry:c136 : 1
m46*0.1
nodelay
--
0
PMID: 12773095, 8156998,7871433,7871432,8662795 The recruitment of STATs to the activated receptors has been shown to be mediated by their SH2 domain and requires the phosphorylation of receptor tyrosine motifs
p45
p49
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c138 : 1
stoichiometry:c139 : 1
stoichiometry:c140 : 1
m30*m1798*0.1
nodelay
--
0
PMID: 12773095,7797460 In the cases of LIFR and OSMR, STAT3 and STAT1, as well as STAT5, activation has been observed, withOSMRbeing the most potent activator of STAT5
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c14 : 1
stoichiometry:c15 : 1
m1797*m3578*0.1
nodelay
--
0
PMID: 12773095 Human OSM has the exceptional capability to recruit two different receptor complexes. It forms both LIFR?gp130 and OSMR?gp130 heterodimers.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c141 : 1
stoichiometry:c142 : 1
stoichiometry:c143 : 1
m24*m42*0.1
nodelay
--
0
PMID: 12773095,7871433,8662591,9182534,10068666 Whereas STAT3 binds to phospho (p)YXXQ motifs (Y767RHQ, Y814FKQ, Y905LPQ and Y915MPQ in gp130; Y981QPQ, Y1001KPQ and Y1028RPQ in LIFR) Whereas STAT3 binds to phospho (p)YXXQ motifs (Y767RHQ, Y814FKQ, Y905LPQ and Y915MPQ in gp130; Y981QPQ, Y1001KPQ and Y1028RPQ in LIFR)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c144 : 1
stoichiometry:c145 : 1
stoichiometry:c146 : 1
m24*m1360*0.1
nodelay
--
0
PMID: 12773095,7871433,8662591,9182534,10068666 Whereas STAT3 binds to phospho (p)YXXQ motifs (Y767RHQ, Y814FKQ, Y905LPQ and Y915MPQ in gp130; Y981QPQ, Y1001KPQ and Y1028RPQ in LIFR) Whereas STAT3 binds to phospho (p)YXXQ motifs (Y767RHQ, Y814FKQ, Y905LPQ and Y915MPQ in gp130; Y981QPQ, Y1001KPQ and Y1028RPQ in LIFR)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c147 : 1
stoichiometry:c148 : 1
stoichiometry:c149 : 1
m30*m1360*0.1
nodelay
--
0
PMID: 12773095,7871433,8662591,9182534,10068666 Whereas STAT3 binds to phospho (p)YXXQ motifs (Y767RHQ, Y814FKQ, Y905LPQ and Y915MPQ in gp130; Y981QPQ, Y1001KPQ and Y1028RPQ in LIFR) Whereas STAT3 binds to phospho (p)YXXQ motifs (Y767RHQ, Y814FKQ, Y905LPQ and Y915MPQ in gp130; Y981QPQ, Y1001KPQ and Y1028RPQ in LIFR)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c168 : 1
stoichiometry:c169 : 1
m47*0.1
nodelay
--
0
PMID: 12773095,7690989,8626374 Subsequent to receptor binding, the STAT factors are phosphorylated on a single tyrosine residue (Tyr701 in STAT1 and Tyr705 in STAT3)
p35
p54
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c150 : 1
stoichiometry:c151 : 1
stoichiometry:c152 : 1
m18*m42*0.1
nodelay
--
0
PMID: 12773095,9716487 All IL-6-type cytokines potently activate STAT3, and to a minor extent STAT1 through their common receptor subunit gp130
p45
p55
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c153 : 1
stoichiometry:c154 : 1
stoichiometry:c155 : 1
m18*m1798*0.1
nodelay
--
0
PMID: 12773095,7797460 In the cases of LIFR and OSMR, STAT3 and STAT1, as well as STAT5, activation has been observed, withOSMRbeing the most potent activator of STAT5
p35
p56
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c156 : 1
stoichiometry:c157 : 1
stoichiometry:c158 : 1
m18*m1360*0.1
nodelay
--
0
PMID: 12773095,9716487 All IL-6-type cytokines potently activate STAT3, and to a minor extent STAT1 through their common receptor subunit gp130
p45
p57
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c159 : 1
stoichiometry:c160 : 1
stoichiometry:c161 : 1
m20*m1798*0.1
nodelay
--
0
PMID: 12773095,7797460 In the cases of LIFR and OSMR, STAT3 and STAT1, as well as STAT5, activation has been observed, withOSMRbeing the most potent activator of STAT5
p35
p58
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c162 : 1
stoichiometry:c163 : 1
stoichiometry:c164 : 1
m20*m42*0.1
nodelay
--
0
PMID: 12773095,9716487 All IL-6-type cytokines potently activate STAT3, and to a minor extent STAT1 through their common receptor subunit gp130
p35
p59
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c165 : 1
stoichiometry:c166 : 1
stoichiometry:c167 : 1
m20*m1360*0.1
nodelay
--
0
PMID: 12773095,9716487 All IL-6-type cytokines potently activate STAT3, and to a minor extent STAT1 through their common receptor subunit gp130
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c17 : 1
stoichiometry:c18 : 1
m5*m14*0.1
nodelay
--
0
PMID: 12773095 IL-6 and IL-11 are the only IL-6-type cytokines that signal via gp130 homodimers.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c170 : 1
stoichiometry:c171 : 1
m48*0.1
nodelay
--
0
PMID: 12773095,7690989,8626374 Subsequent to receptor binding, the STAT factors are phosphorylated on a single tyrosine residue (Tyr701 in STAT1 and Tyr705 in STAT3)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c172 : 1
stoichiometry:c173 : 1
m49*0.1
nodelay
--
0
PMID: 12773095,7690989,8626374 Subsequent to receptor binding, the STAT factors are phosphorylated on a single tyrosine residue (Tyr701 in STAT1 and Tyr705 in STAT3)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c174 : 1
stoichiometry:c175 : 1
stoichiometry:c176 : 1
m66*m42*0.1
nodelay
--
0
PMID: 12773095 Arg31 of STAT1 was found to be specifically methylated by PRMT-1 (protein arginine methyltransferase-1).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c177 : 1
stoichiometry:c178 : 1
stoichiometry:c179 : 1
m66*m38*0.1
nodelay
--
0
PMID: 12773095,9029147 Therewas earlier evidence for a link between PRMT and the JAK/STAT pathway: PRMT-1 was found to associate with the IFN¦Á/¦Â receptor 1; and also a JAK-associated protein was identified as PRMT-5
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c180 : 1
stoichiometry:c181 : 1
stoichiometry:c182 : 1
m66*m69*0.1
nodelay
--
0
PMID: 12773095,9029147 Therewas earlier evidence for a link between PRMT and the JAK/STAT pathway: PRMT-1 was found to associate with the IFN¦Á/¦Â receptor 1; and also a JAK-associated protein was identified as PRMT-5
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c183 : 1
stoichiometry:c203 : 1
stoichiometry:c189 : 1
m71*m80*0.1
nodelay
--
0
PMID: 12773095,9918120 Indeed, extracellularsignal- dependent translocation of STAT1 in response to IFN requires the nuclear import receptor NPI-1/importin-¦Á5, which mediates translocation via a Ran-dependent mechanism PMID: 12773095,11927559,11823427 Later it turned out that residues located within this short sequence stretch are important for the interaction of STAT1 with the import receptor importin-¦Á5 and therefore for nuclear import of STAT1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c184 : 1
stoichiometry:c185 : 1
stoichiometry:c186 : 1
m76*m73*0.1
nodelay
--
0
PMID: 12773095,9918120 Indeed, extracellularsignal- dependent translocation of STAT1 in response to IFN requires the nuclear import receptor NPI-1/importin-¦Á5, which mediates translocation via a Ran-dependent mechanism
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c190 : 1
stoichiometry:c191 : 1
stoichiometry:c192 : 1
m76*m72*0.1
nodelay
--
0
PMID: 12773095,9918120 Indeed, extracellularsignal- dependent translocation of STAT1 in response to IFN requires the nuclear import receptor NPI-1/importin-¦Á5, which mediates translocation via a Ran-dependent mechanism
p65
p68
cso30:i:ME_Translocation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c193 : 1
stoichiometry:c194 : 1
stoichiometry:c195 : 1
stoichiometry:c196 : 1
m71*m75*m1357*0.1
nodelay
--
0
PMID: 12773095,9918120 Indeed, extracellularsignal- dependent translocation of STAT1 in response to IFN requires the nuclear import receptor NPI-1/importin-¦Á5, which mediates translocation via a Ran-dependent mechanism
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c197 : 1
stoichiometry:c198 : 1
stoichiometry:c199 : 1
m76*m79*0.1
nodelay
--
0
PMID: 12773095,11080165,10973496 Sensitivity to leptomycin suggests that nuclear export of STAT1 involves the nuclear export receptor CRM-1 that also acts in a Randependent manner
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c21 : 1
m6*m14*0.1
nodelay
--
0
PMID: 12773095 IL-6 and IL-11 are the only IL-6-type cytokines that signal via gp130 homodimers.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c200 : 1
stoichiometry:c201 : 1
stoichiometry:c202 : 1
m78*m77*0.1
nodelay
--
0
PMID: 12773095,11080165,10973496 Sensitivity to leptomycin suggests that nuclear export of STAT1 involves the nuclear export receptor CRM-1 that also acts in a Randependent manner
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c187 : 1
stoichiometry:c188 : 1
stoichiometry:c204 : 1
m74*m1357*0.1
nodelay
--
0
PMID: 12773095,11927559,11823427 Later it turned out that residues located within this short sequence stretch are important for the interaction of STAT1 with the import receptor importin-¦Á5 and therefore for nuclear import of STAT1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c205 : 1
stoichiometry:c206 : 1
stoichiometry:c207 : 1
m25*m81*0.1
nodelay
--
0
PMID: 12773095,11016927 It has been demonstrated that the adaptor protein Shc (SH2- and collagen-homology-domain-containing protein)is recruited to the receptor via Tyr861 in the cytoplasmic region of the OSMR
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c208 : 1
stoichiometry:c209 : 1
m22*0.1
nodelay
--
0
PMID: 12773095, 8156998,7871433,7871432,8662795 The recruitment of STATs to the activated receptors has been shown to be mediated by their SH2 domain and requires the phosphorylation of receptor tyrosine motifs
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c210 : 1
stoichiometry:c211 : 1
stoichiometry:c212 : 1
stoichiometry:c220 : 1
m85*m86*0.1
nodelay
--
0
PMID: 12773095,9794795 SHP2 is rapidly recruited to tyrosine-phosphorylated gp130 and becomes also phosphorylated in a JAK1-dependent manner
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c213 : 1
stoichiometry:c214 : 1
m87*0.1
nodelay
--
0
PMID: 12773095,9794795 SHP2 is rapidly recruited to tyrosine-phosphorylated gp130 and becomes also phosphorylated in a JAK1-dependent manner
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c215 : 1
stoichiometry:c216 : 1
stoichiometry:c217 : 1
m89*m88*0.1
nodelay
--
0
PMID: 12773095,9195977,8596638,9885561 According to the current viewof the SHP2-dependent activation of MAPKs adopted from EGF and PDGF (platelet-derived growth factor) signal transduction, SHP2 links the Grb2?SOS (growthfactor- receptor-bound protein/Son of Sevenless) complex and/or Gab1 (Grb2-associated binder-1) to gp130
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c218 : 1
stoichiometry:c219 : 1
stoichiometry:c221 : 1
m88*m91*0.1
nodelay
--
0
PMID: 12773095,9195977,8596638,9885561 According to the current viewof the SHP2-dependent activation of MAPKs adopted from EGF and PDGF (platelet-derived growth factor) signal transduction, SHP2 links the Grb2?SOS (growthfactor- receptor-bound protein/Son of Sevenless) complex and/or Gab1 (Grb2-associated binder-1) to gp130
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c222 : 1
stoichiometry:c223 : 1
m84*0.1
nodelay
--
0
PMID: 12773095 The alternative Shc-mediated pathway mediated by OSM also involves the adaptor protein Grb2 which is recruited to Tyr317- phosphorylated Shc
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c224 : 1
stoichiometry:c225 : 1
stoichiometry:c226 : 1
m83*m93*0.1
nodelay
--
0
PMID: 12773095 The alternative Shc-mediated pathway mediated by OSM also involves the adaptor protein Grb2 which is recruited to Tyr317- phosphorylated Shc.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c23 : 1
stoichiometry:c24 : 1
m3578*m1080*0.1
nodelay
--
0
PMID: 12773095 The remaining IL-6 type cytokines signal via heterodimers of either gp130 and the LIFR (LIF, CNTF, CT-1 and CLC) or gp130 and the OSMR (OSM).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c227 : 1
stoichiometry:c228 : 1
stoichiometry:c229 : 1
m94*m1720*0.1
nodelay
--
0
PMID: 12773095 Finally, recruitment of SOS to the receptor complex at the membrane allows Ras activation, which in turn leads to the activation of the Ras?Raf?MAPK cascade
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c231 : 1
stoichiometry:c230 : 1
stoichiometry:c232 : 1
m97*m95*0.1
nodelay
--
0
PMID: 12773095 Finally, recruitment of SOS to the receptor complex at the membrane allows Ras activation, which in turn leads to the activation of the Ras?Raf?MAPK cascade
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c233 : 1
stoichiometry:c234 : 1
stoichiometry:c235 : 1
m96*m98*0.1
nodelay
--
0
PMID: 12773095 Finally, recruitment of SOS to the receptor complex at the membrane allows Ras activation, which in turn leads to the activation of the Ras?Raf?MAPK cascade
p83
p83
cso30:i:ME_Translation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c238 : 1
stoichiometry:c239 : 1
stoichiometry:c240 : 1
m155666*m94757*0.1
nodelay
--
0
PMID: 12773095,10453004 A similar mechanism has been discovered for IFN¦Ã signalling, where LPS inhibits IFN¦Ã -dependent STAT1 activation also via the induction of SOCS3
p84
p84
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c241 : 1
stoichiometry:c242 : 1
stoichiometry:c244 : 1
stoichiometry:c243 : 1
m1639*m42*0.1
nodelay
--
0
PMID: 12773095,10453004 A similar mechanism has been discovered for IFN¦Ã signalling, where LPS inhibits IFN¦Ã -dependent STAT1 activation also via the induction of SOCS3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c245 : 1
stoichiometry:c246 : 1
stoichiometry:c247 : 1
m41*m72733*0.1
nodelay
--
0
PMID: 12773095,9037008,8986769,10464260 The C-terminal transactivation domains of STAT1, STAT3 and STAT5 are known to interact with CBP/p300
p85
p86
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c248 : 1
stoichiometry:c249 : 1
stoichiometry:c250 : 1
m72733*m1357*0.1
nodelay
--
0
PMID: 12773095,9037008,8986769,10464260 The C-terminal transactivation domains of STAT1, STAT3 and STAT5 are known to interact with CBP/p300
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c251 : 1
stoichiometry:c252 : 1
stoichiometry:c253 : 1
m43*m72733*0.1
nodelay
--
0
PMID: 12773095,9037008,8986769,10464260 The C-terminal transactivation domains of STAT1, STAT3 and STAT5 are known to interact with CBP/p300
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c254 : 1
stoichiometry:c255 : 1
stoichiometry:c256 : 1
m41*m4512*0.1
nodelay
--
0
PMID: 12773095,9037008,8986769,10464260 The C-terminal transactivation domains of STAT1, STAT3 and STAT5 are known to interact with CBP/p300
p85
p89
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c257 : 1
stoichiometry:c258 : 1
stoichiometry:c259 : 1
m1357*m4512*0.1
nodelay
--
0
PMID: 12773095,9037008,8986769,10464260 The C-terminal transactivation domains of STAT1, STAT3 and STAT5 are known to interact with CBP/p300
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c26 : 1
stoichiometry:c25 : 1
stoichiometry:c27 : 1
m3578*m11*0.1
nodelay
--
0
PMID: 12773095 The remaining IL-6 type cytokines signal via heterodimers of either gp130 and the LIFR (LIF, CNTF, CT-1 and CLC) or gp130 and the OSMR (OSM).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c260 : 1
stoichiometry:c261 : 1
stoichiometry:c262 : 1
m43*m4512*0.1
nodelay
--
0
PMID: 12773095,9037008,8986769,10464260 The C-terminal transactivation domains of STAT1, STAT3 and STAT5 are known to interact with CBP/p300
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c263 : 1
stoichiometry:c264 : 1
stoichiometry:c265 : 1
m101*m2131*0.1
nodelay
--
0
PMID: 12773095,9989503 This interaction is further modulated by Nmi (N-Myc interactor) which augments CBP recruitment to STAT1 and STAT5, and potentiates IL-2 and IFN¦Ã signalling
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c266 : 1
stoichiometry:c267 : 1
stoichiometry:c268 : 1
m102*m2131*0.1
nodelay
--
0
PMID: 12773095,9989503 This interaction is further modulated by Nmi (N-Myc interactor) which augments CBP recruitment to STAT1 and STAT5, and potentiates IL-2 and IFN¦Ã signalling
p93
p93
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c270 : 1
stoichiometry:c271 : 1
stoichiometry:c269 : 1
m94491*m1954*0.1
nodelay
--
0
PMID: 12773095 Interestingly, Nmi itself is induced by IL-2 and IFN¦Ã , indicating a positive feedback loop within this signal transduction.
p93
p94
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c273 : 1
stoichiometry:c274 : 1
stoichiometry:c272 : 1
m1639*m94491*0.1
nodelay
--
0
PMID: 12773095 Interestingly, Nmi itself is induced by IL-2 and IFN¦Ã , indicating a positive feedback loop within this signal transduction.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c275 : 1
stoichiometry:c276 : 1
stoichiometry:c277 : 1
m10730*m43*0.1
nodelay
--
0
PMID: 12773095,11726519 The nuclear receptor co-repressor SMRT (silencing mediator of retinoic and thyroid hormone receptors) is a potential binding partner for STAT5 and represses STAT5-dependent transcription
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c278 : 1
stoichiometry:c279 : 1
stoichiometry:c280 : 1
m110*m109*0.1
nodelay
--
0
PMID: 12773095,12456685 Furthermore, FKHR and STAT3 can be co-immunoprecipitated and co-localize in the nucleus of IL-6-treated HepG2 cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c281 : 1
stoichiometry:c283 : 1
stoichiometry:c282 : 1
m5*m111*0.1
nodelay
--
0
PMID:12773095 These results indicate that FKHR can modulate the IL-6-induced transcriptional activity by enhancing STAT3 action.
p98
p98
cso30:i:ME_Phosphorylation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c284 : 1
stoichiometry:c285 : 1
stoichiometry:c286 : 1
m113*m110*0.1
nodelay
--
0
PMID: 12773095,1372389,10462375 FKHR is inactivated by Akt/protein kinase B-mediated serine/threonine phosphorylation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c287 : 1
stoichiometry:c288 : 1
stoichiometry:c289 : 1
m115*m109*0.1
nodelay
--
0
PMID: 12773095 STAT3 and EZI physically interact as demonstrated by co-immunoprecipitation.
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--